细胞外囊泡 (EVs):在心脏组织再生中是一个有前途的治疗工具
Francesca Diomede1, Simone Guarnieri2, Paola Lanuti3
1Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
BioFactors (Oxford, England)
|December 22, 2023
概括
人类牙纸干细胞衍生的细胞外囊泡 (EVs) 显示了心肌原生差异化的潜力. 这些EV可能会为心脏修复疗法提供更安全,更具成本效益的替代性介质干细胞 (MSCs).
科学领域:
- 心血管研究研究心血管研究
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 介质细胞干细胞 (MSCs) 正在探索心脏修复,其中EVs是关键的膜效应器.
- 来自MSC的细胞外囊泡 (EV) 对它们的再生能力至关重要.
- 牙纸干细胞 (hDPSCs) 提供了一个潜在的更安全和更具成本效益的替代方案,而不是MSCs.
研究的目的:
- 研究人类牙纸干细胞衍生的EVs在促进心肌性分化方面的潜力.
- 评估来自hDPSCs和HL-1心肌细胞系的EVs在调节心脏细胞系分化中的作用.
- 在这种分化过程中探索潜在的表观遗传机制,特别是微RNA调节.
主要方法:
- 免疫光学,实时PCR和西部斑点测试用于评估心肌原性标记物表达 (GATA4,ACTC1,CX43,Nkx2.5).
- 分析了GATA4的标微RNAhsa-miR-200c-3p的表达概况.
- 使用hDPSCs的体外模型被开发用于研究EV介导的分化.
主要成果:
- 与对照组相比,用EV处理的细胞 (来自hDPSC和HL-1细胞) 中hsa-miR-200c-3p的下调显著.
- 这种下调表明潜在的表观遗传机制涉及hsa-miR-200c-3p在其目标基因GATA4的上调.
- 来自hDPSCs和HL-1细胞的EVs影响了向心肌性血统的分化过程.
结论:
- 由hDPSCs衍生出的EV对心肌原生差异化有希望,为MSCs提供了可行的替代方案.
- EVs调节心脏分化,可能是通过涉及微RNA的表观遗传机制.
- 这项研究为治疗心脏病的新型无细胞治疗策略铺平了道路.
更多相关视频
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
281
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
6.1K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
